inactiv
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
test
candid
vaccin
reemerg
sar
order
understand
efficaci
safeti
approach
import
know
antibodi
specif
gener
inactiv
sarscov
current
studi
panel
twelv
monoclon
antibodi
mab
establish
immun
balbc
mice
inactiv
strain
sarscov
isol
lung
tissu
sarsinfect
chines
patient
mab
could
recogn
sarscovinfect
cell
immunofluoresc
analysi
ifa
seven
map
specif
segment
recombin
spike
protein
six
subunit
aa
one
subunit
aa
high
neutral
titer
sarscov
detect
two
mab
target
subdomain
protein
aa
consist
previou
report
segment
protein
contain
major
neutral
domain
sspecif
mab
abl
recogn
cleav
product
protein
sarscovinfect
vero
cell
none
remain
five
mab
could
recogn
either
recombin
n
e
antigen
elisa
studi
demonstr
inactiv
sarscov
abl
preserv
immunogen
protein
includ
major
neutral
domain
rel
eas
mab
gener
sarscov
virion
support
subunit
vaccin
construct
may
also
abl
protect
anim
perhap
human
somewhat
unexpect
nspecif
mab
identifi
albeit
antin
igg
easili
identifi
sarscovinfect
patient
avail
panel
mab
also
provid
potenti
use
agent
applic
therapi
diagnosi
basic
research
sarscov
epitop
map
biolog
function
analysi
antibodi
produc
immun
mice
inactiv
chines
isol
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
sever
acut
respiratori
syndrom
sar
highli
virul
emerg
infecti
diseas
spread
rapidli
among
larg
human
popul
demonstr
first
half
etiolog
agent
sar
identifi
new
human
coronaviru
sarscov
marra
et
al
rota
et
al
first
sar
epidem
success
contain
collabor
effort
organ
world
health
organ
sar
remain
potenti
threat
due
mysteri
sourc
initi
infect
highli
transmitt
natur
viru
callow
et
al
kraaijeveld
et
al
appar
presenc
anim
reservoir
provid
possibl
reemerg
includ
form
increas
infect
symptom
sar
confus
clinic
mani
respiratori
diseas
caus
see
front
matter
elsevi
inc
right
reserv
etiolog
agent
simpl
highli
specif
diagnost
test
applic
earli
onset
sar
still
need
develop
current
medic
strategi
mainli
reli
nonspecif
antivir
support
treatment
suffici
question
remain
whether
natur
sar
infect
ever
return
form
seen
import
test
variou
candid
sarscov
vaccin
produc
tool
use
diagnos
treat
infect
reemerg
sarscov
envelop
positivesens
singlestrand
rna
viru
nucleotid
complet
sequenc
open
read
frame
orf
analysi
analog
known
coronavirus
indic
four
structur
protein
might
play
import
function
associ
sarscov
infect
includ
surfac
spike
protein
aa
ntermin
receptor
bind
domain
mediat
attach
cellular
receptor
lewicki
gallagh
wong
et
al
ctermin
heptad
repeat
hr
promot
viru
entri
fusion
cell
membran
bosch
et
al
luo
weiss
marra
et
al
rota
et
al
spiga
et
al
nucleocapsid
n
protein
aa
highli
basic
structur
protein
usual
known
bind
viral
rna
form
helic
core
structur
coronaviru
davi
et
al
promot
viral
packag
viral
core
format
et
al
hiscox
et
al
matrix
membran
glycoprotein
aa
integr
membran
protein
involv
bud
small
envelop
protein
e
aa
critic
compon
viru
respons
virion
envelop
morphogenesi
arb
et
al
act
scaffold
protein
trigger
assembl
sarscov
lack
envelopeassoci
hemagglutininesteras
glycoprotein
encod
coronavirus
addit
genom
fragment
code
rnadepend
rnapolymeras
eight
nonstructur
protein
marra
et
al
rota
et
al
sinc
discoveri
sarscov
caus
sar
inactiv
sarscov
propos
one
prophylact
vaccin
approach
sar
anim
earli
phase
human
studi
start
darnel
et
al
et
al
marshal
enserink
takasuka
et
al
tang
et
al
xiong
et
al
howev
breadth
specif
antibodi
respons
anim
immun
inactiv
sarscov
well
character
time
number
studi
map
major
neutral
domain
sarscov
protein
amino
acid
sui
et
al
epitop
coincid
angiotensinconvert
enzym
receptor
bind
site
identifi
protein
vero
cell
infect
sarscov
berri
et
al
che
et
al
et
al
hua
et
al
li
et
al
sui
et
al
ter
meulen
et
al
traggiai
et
al
wen
et
al
wong
et
al
zhou
et
al
current
studi
panel
monoclon
antibodi
produc
mice
immun
inactiv
sarscov
isol
infect
patient
qin
et
al
tang
et
al
spectrum
antibodi
respons
elicit
inactiv
sarscov
examin
result
suggest
mab
gener
approach
recogn
quit
divers
epitop
protein
three
structur
protein
n
e
sspecif
mab
show
differ
biolog
activ
virionassoci
antigen
may
resembl
true
topolog
sarscov
antigen
close
recombin
sarscov
protein
current
studi
produc
panel
mab
epitop
may
otherwis
recogn
thu
provid
use
tool
wide
rang
potenti
applic
relat
sar
research
posit
antibodi
respons
sarscov
identifi
five
balbc
mice
immun
three
time
inactiv
sarscov
fusion
spleen
cell
sp
myeloma
sever
round
screen
twelv
individu
hybridoma
final
obtain
show
antibodi
respons
sarscov
verifi
ifa
stain
sarscovinfect
vero
cell
data
shown
antigen
specif
map
elisa
recombin
sarscov
structur
protein
six
mab
show
highlevel
reactiv
fulllength
recombin
spike
protein
produc
mammalian
express
system
fig
remain
mab
show
poor
reactiv
protein
fig
also
fail
recogn
recombin
e
n
subsequ
elisa
test
data
shown
protein
sarscov
larg
typei
transmembran
glycoprotein
compos
amino
acid
includ
ntermin
domain
ctermin
domain
marra
et
al
rota
et
al
spiga
et
al
use
individu
segment
fig
map
epitop
six
mab
show
high
reactiv
fulllength
protein
design
aa
aa
domain
current
studi
base
knowledg
protein
structur
coronavirus
gener
lai
holm
align
sarscov
protein
sequenc
protein
coronavirus
known
cleavag
site
domain
bosch
et
al
krokhin
et
al
marra
et
al
rota
et
al
spiga
et
al
howev
direct
evid
literatur
suggest
protein
sarscov
cleav
studi
segment
divid
two
subseg
aa
aa
base
distribut
predict
nglycan
site
segment
divid
aa
aa
latter
report
site
bind
sarscov
protein
receptor
ace
recombin
segment
protein
produc
transient
transfect
cell
use
antigen
elisa
western
blot
analys
three
mab
map
two
mab
one
domain
base
result
elisa
tabl
specif
mab
confirm
western
blot
analysi
recogn
specif
recombin
protein
fragment
fig
show
exampl
one
mab
whose
specif
map
domain
elisa
fig
confirm
fig
epitop
map
mab
protein
elisa
mab
ad
dilut
well
either
recombin
fulllength
protein
bar
shade
express
transient
transfect
cell
vector
dnatransfect
cell
bar
blank
bq
control
sera
new
zealand
rabbit
immun
either
fulllength
dna
vaccin
empti
vector
dna
respect
od
valu
less
consid
nonspecif
bind
fulllength
antigen
elisa
assay
western
blot
recognit
recombin
protein
sarscov
virion
associ
antigen
recombin
protein
fig
similarli
epitop
mab
map
respect
tabl
anoth
mab
map
domain
elisa
tabl
recogn
virusassoci
fulllength
antigen
oligom
also
smaller
fragment
kda
like
cleav
fig
interestingli
two
sspecif
mab
identifi
elisa
screen
show
recognit
recombin
protein
western
blot
tabl
suggest
mab
may
mainli
recogn
nondenatur
epitop
unexpectedli
anoth
mab
fail
show
reactiv
fulllength
antigen
either
elisa
fig
western
blot
recogn
recombin
protein
fig
consist
find
mab
recogn
lower
molecular
band
fulllength
associ
sarscov
virion
fig
addit
elisa
analysi
map
epitop
first
aa
protein
mab
show
low
clearli
posit
reactiv
antigen
fig
tabl
map
sspecif
mab
elisa
western
blot
analys
mab
recombin
antigen
recogn
elisa
western
blot
vector
nd
nd
done
detect
subdomain
western
blot
analysi
sampl
includ
uninfect
vero
cell
lysat
vero
sarscovinfect
vero
cell
lysat
sarscov
recombin
protein
label
infect
vero
lysat
recombin
protein
express
transient
transfect
cell
control
cell
transfect
vector
dna
b
elisa
mab
dilut
differ
recombin
antigen
express
transient
transfect
cell
control
cell
transfect
vector
dna
od
valu
less
consid
nonspecif
bind
elisa
assay
twelv
mab
test
studi
two
specif
mab
show
signific
level
neutral
activ
sarscov
fig
two
sspecif
mab
epitop
domain
show
borderlin
neutral
activ
remain
three
sspecif
mab
demonstr
neutral
activ
fig
neutral
titer
mab
measur
inhibit
sarscov
infect
summar
tabl
along
origin
concentr
sspecif
igg
mab
panel
mab
character
respect
immunoglobulin
isotyp
analys
constant
region
heavi
chain
show
five
five
one
one
igm
tabl
use
n
light
chain
instead
e
chain
two
mab
show
strong
neutral
activ
sarscov
isotyp
respect
current
studi
confirm
inactiv
sarscov
immunogen
elicit
antibodi
respons
sarscov
antigen
less
like
inactiv
sarscov
complet
reflect
antigen
conform
sarscov
data
reveal
protein
domin
antigen
among
virionassoci
protein
major
mab
produc
studi
specif
protein
includ
two
fig
neutral
activ
mab
urbani
strain
sarscov
measur
neutral
red
stain
infect
vero
cell
neutral
activ
plot
percent
inhibit
viral
infect
particular
rabbit
serum
dilut
base
geometr
mean
triplet
well
inhibit
inhibit
level
mark
excel
neutral
activ
sarscov
infect
fig
interest
none
mab
could
recogn
n
e
antigen
even
though
antin
antibodi
report
one
major
antibodi
compon
sarscovinfect
patient
sera
ying
et
al
find
differ
recent
vitro
studi
use
subunit
sarscov
antigen
protein
interact
n
protein
ctermin
domain
facilit
format
nucleocapsid
also
report
abl
interact
protein
form
pseudoparticl
studi
dna
vaccin
express
n
antigen
elicit
high
titer
antin
antibodi
respons
thu
rule
possibl
n
poor
immunogen
epitop
identifi
five
mab
produc
immun
inactiv
sarscov
like
mab
may
recogn
antigen
determin
uniqu
inactiv
virion
possibl
mab
recogn
nonstructur
protein
exist
less
like
sinc
mab
initi
select
base
reactiv
inactiv
virion
elisa
knowledg
relat
specif
antibodi
respons
gener
inactiv
sarscov
vaccin
import
evalu
efficaci
safeti
profil
vaccin
approach
sar
viral
enhanc
antibodi
autoimmun
respons
report
inactiv
vaccin
approach
anim
coronavirus
marshal
enserink
scott
data
use
identif
contribut
compon
autoimmun
respons
candid
inactiv
sarscov
vaccin
eventu
demonstr
similar
advers
event
advanc
human
test
current
studi
twelv
mab
human
sarscov
produc
immun
balbc
mice
inactiv
patient
isol
sarscov
differ
approach
produc
anti
mab
mab
isol
sarscovinfect
patient
igg
memori
b
lymphocyt
immort
ebv
traggiai
et
al
mice
receiv
high
dose
one
mab
protect
viral
challeng
traggiai
et
al
anoth
studi
show
mab
specif
nucleoprotein
five
mab
react
spike
protein
seventeen
igg
mab
screen
elisa
abl
neutral
sarscov
vitro
berri
et
al
human
mab
gener
antibodi
phage
display
technolog
screen
larg
naiv
antibodi
librari
could
reduc
replic
sarscov
prophylact
administr
ferret
ter
meulen
et
al
sever
mab
rais
use
recombin
protein
fragment
sar
cov
protein
residu
n
protein
express
escherichia
coli
berri
et
al
che
et
al
wen
et
al
synthet
gene
fragment
predict
epitop
also
use
rais
mab
studi
domain
structur
hua
et
al
recombin
antibodi
e
n
protein
isol
mous
synthet
v
h
v
l
scfv
phage
display
librari
high
bind
affin
sar
protein
e
n
purifi
e
coli
studi
use
inactiv
vaccin
approach
immun
mice
result
mab
show
divers
specif
variou
biolog
function
data
confirm
domin
neutral
domain
protein
region
coincid
receptor
bind
region
protein
report
previous
sui
et
al
specif
strength
two
high
titer
neutral
mab
indistinguish
experi
thu
probabl
recogn
close
relat
epitop
rel
eas
mab
gener
support
idea
subunit
vaccin
construct
may
suffici
protect
anim
perhap
human
two
three
mab
also
show
slightli
posit
neutral
activ
howev
low
neutral
titer
would
support
role
region
anoth
neutral
domain
two
mab
may
recogn
region
protein
interfer
bind
virion
viral
receptor
may
direct
manner
seven
mab
panel
specif
protein
six
show
strong
bind
fulllength
protein
seventh
mab
could
recogn
process
antigen
sarscov
appar
molecular
weight
kda
fig
epitop
map
region
fig
quit
uniqu
could
recogn
either
fulllength
recombin
protein
virionassoci
fulllength
protein
direct
interpret
find
epitop
region
may
access
fulllength
protein
given
larg
size
heavi
glycosyl
sarscov
protein
addit
analys
need
confirm
whether
epitop
may
becom
expos
upon
cleavag
smaller
fragment
recent
demonstr
protein
sarscov
may
go
stepwis
cleavag
process
highli
specif
polyclon
antibodi
recogn
group
low
molecular
weight
fragment
rather
explicit
domain
wang
et
al
report
suggest
protein
sarscov
normal
process
subunit
howev
could
cleav
exogen
trypsin
simmon
et
al
yao
et
al
current
studi
cleav
fragment
kda
identifi
mab
western
blot
analysi
find
consist
observ
recent
public
product
detect
mab
gener
purifi
recombin
protein
data
reveal
import
evid
protein
cleav
lysat
sarscovinfect
vero
cell
indic
presenc
proteolyt
process
protein
process
may
cell
depend
cleavag
observ
recombin
protein
transfect
cell
avail
specif
cellular
enzym
may
critic
cleavag
discoveri
mab
specif
process
protein
specif
aid
studi
proteocleavag
protein
known
igg
subclass
may
show
differ
effector
function
like
antigen
recognit
complement
activ
cell
surfac
fc
receptor
bind
whitton
oldston
exampl
human
antibodi
viral
capsid
protein
found
belong
predominantli
subclass
wherea
predomin
subclass
immun
respons
polysaccharid
therefor
studi
immunoglobulin
isotyp
also
analyz
although
known
classif
mous
igg
subclass
match
human
among
igg
mab
produc
studi
five
five
one
two
strong
neutral
mab
respect
previous
report
neutral
mab
sarscov
includ
sui
et
al
subtyp
gubbin
et
al
evid
suggest
antibodi
isotyp
may
play
role
determin
neutral
activ
sarscov
conclus
character
twelv
mab
gener
inactiv
sarscov
major
mab
recogn
either
fulllength
process
protein
wide
spectrum
protein
epitop
recogn
panel
mab
suggest
overal
high
immunogen
protein
associ
sarscov
particl
antibodi
sarscov
protein
includ
linear
conform
epitop
thu
mab
use
tool
specif
applic
sar
research
sarscov
strain
qin
et
al
isol
sar
patient
beij
china
institut
microbiolog
epidemiolog
beij
china
fang
et
al
vero
cell
cell
infect
multipl
infect
moi
cultur
co
h
cell
lyse
freezethaw
cycl
follow
centrifug
rpm
beckman
beckman
coulter
inc
fullerton
ca
min
prepar
inactiv
sarscov
previous
report
tang
et
al
briefli
viru
inactiv
hpropiolacton
dilut
commerci
stock
solut
gml
sigmaaldrich
st
loui
mo
incub
h
kept
h
inactiv
viru
suspens
centrifug
rpm
beckman
beckman
coulter
inc
min
supernat
harvest
concentr
sigmaaldrich
inc
concentr
centrifug
g
min
use
cetriplu
millipor
corp
bedford
follow
purif
sepharos
column
chromatographi
tang
et
al
sarscov
urbani
strain
use
neutral
assay
obtain
us
center
diseas
control
prevent
atlanta
ga
inactiv
viru
elisa
western
blot
analysi
viru
stock
first
filter
membran
remov
cell
debri
viru
inactiv
buffer
contain
sd
tritonx
trisbuff
salin
ph
h
inactiv
sarscov
confirm
use
standard
oper
procedur
sop
approv
institut
biosafeti
committe
univers
massachusett
medic
school
sixweekold
balbc
mice
inject
ag
inactiv
sarscov
strain
mix
complet
freund
adjuv
cfa
ra
difco
day
day
mice
receiv
ag
inactiv
sarscov
incomplet
freund
adjuv
ifa
mice
boost
week
later
ag
inactiv
sarscov
without
adjuv
anim
euthan
day
later
mous
splenocyt
fuse
sp
myeloma
cell
posit
hybridoma
clone
supernat
screen
via
elisa
use
inactiv
viru
coat
antigen
fuse
cell
line
posit
elisa
grown
briefli
cell
cultur
inject
mous
peritoneum
ascit
fluid
contain
high
titer
monoclon
antibodi
sarscov
collect
analysi
immunoglobulin
isotyp
perform
use
commerci
dipstick
test
roch
accord
manufactur
instruct
codon
usag
publish
sarscov
n
e
gene
sequenc
marra
et
al
rota
et
al
analyz
macvector
softwar
v
accelri
san
diego
ca
homo
sapien
genom
less
optim
codon
gene
chang
codon
prefer
mammalian
system
promot
higher
express
structur
protein
codonoptim
gene
chemic
synthes
geneart
regensburg
germani
individu
subclon
dna
vaccin
vector
human
tissu
plasminogen
activ
tpa
leader
sequenc
replac
natur
leader
construct
report
wang
et
al
sarscov
dna
plasmid
transform
e
coli
strain
confirm
dna
sequenc
larg
amount
dna
plasmid
prepar
mega
purif
kit
qiagen
valencia
ca
recombin
protein
use
studi
produc
transient
transfect
cell
dna
construct
first
transfect
cell
use
calcium
phosphat
precipit
method
report
wang
et
al
briefli
cell
confluenc
dish
transfect
ag
plasmid
dna
harvest
h
later
elisa
western
blot
use
highbind
flatbottom
plate
costar
coat
overnight
al
sarscov
antigen
agml
enhanc
antigen
bind
plate
first
incub
al
cona
agml
h
room
temperatur
wash
time
pb
contain
triton
plate
block
alwel
block
buffer
nonfat
dri
milk
whey
tween
pb
ph
h
five
wash
al
serial
dilut
mab
ad
duplic
well
incub
h
anoth
set
wash
plate
incub
h
room
temperatur
al
antimous
igg
conjug
horseradish
peroxidas
southernbiotech
birmingham
al
dilut
whey
dilut
buffer
whey
tween
pb
final
wash
plate
develop
tetramethybenzidin
solut
alwel
sigma
st
loui
mo
min
reaction
stop
ad
al
h
plate
read
od
nm
quantiti
mousepurifi
mab
determin
use
standard
igg
igm
southern
biotech
elisa
assay
purifi
sarscov
virion
transient
express
antigen
first
run
sdspage
electrophoresi
sampl
heat
min
sampl
buffer
mm
trishcl
ph
mm
dithiothreitol
sd
bromophenol
blue
glycerol
equal
amount
transient
express
antigen
load
per
lane
gel
gel
electroblot
pvdf
membran
biorad
use
h
block
overnight
block
buffer
iblock
tween
pb
membran
incub
dilut
mab
wash
blot
incub
alkalin
phosphataseconjug
goat
antirabbit
igg
dilut
signal
detect
use
chemiluminesc
westernlight
kit
tropix
bedford
sarscov
neutral
assay
use
neutral
red
stain
perform
triplic
test
well
flat
bottom
plate
laboratori
initi
tcid
viru
alwel
incub
al
serial
dilut
rabbit
sera
tissu
cultur
medium
h
incub
al
vero
cell
cell
ad
well
moi
day
infect
cell
form
cpe
viral
control
well
cultur
medium
remov
test
well
al
neutral
red
dmem
medium
ad
well
incub
h
neutral
red
medium
remov
plate
wash
twice
pb
ph
al
acid
alcohol
acet
acid
ethanol
ad
well
incub
min
room
temperatur
absorb
read
percent
neutral
given
serum
dilut
determin
calcul
differ
absorpt
test
well
cell
serum
sampl
viru
viru
control
well
cell
viru
divid
result
differ
absorpt
cell
control
well
cell
viru
control
well
montefiori
et
al
assay
system
sera
consid
posit
neutral
antibodi
activ
titer
inhibit
compar
viru
control
